VectorBuilder
PrivateLast Round
Series C
Extension
Jul 26, 2023
Est. Valuation
$1B
Total Funding Raised
$76M
Company Overview
VectorBuilder is a biotechnology company that provides a full spectrum of gene delivery solutions, including an online platform for vector design, custom cloning, virus packaging, and CDMO services for research and clinical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VectorBuilder Comparables
Compare VectorBuilder with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PackGene Biotech | 88% | |
| GenScript | 84% | |
| Charles River Laboratories | 79% |
VectorBuilder Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jul 26, 2023 | ||||
| Series C | Oct 1, 2022 |
VectorBuilder Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Legend Capital | Series C |
| Guangzhou Yuexiu Industrial Investment Fund Management | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2026
Attending the ARVO Annual Meeting in Denver, Colorado.
- Apr 14, 2026
Launched MuteFree AAV for gene therapy development.
Recent news
Latest coverage and updates
- partners_withAug 18, 2026
VectorBuilder Inc. partnered with Lirtx on Aug 18th '26.
- is_developingAug 18, 2026
VectorBuilder Inc. is developing adeno-associated virus capsids on Aug 18th '26.
- launchesJul 14, 2026
VectorBuilder Inc. launched major update to VectorBee on Jul 14th '26.
- invests_into_assetsJul 9, 2026
VectorBuilder Inc. will invest into assets: 35,000-square-foot (sf) life sciences facility in the amount of $50M in Chicago, Illinois, United States, Northern America, Americas on Jul 1st '27.
- expands_facilitiesJul 9, 2026
VectorBuilder Inc. will expand facilities to Chicago, Illinois, United States, Northern America, Americas on Jul 1st '27.
VectorBuilder Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VectorBuilder's valuation, stock price, and market status.
Is VectorBuilder a public or private company?
VectorBuilder is a private company.
What is the current stock price of VectorBuilder?
VectorBuilder is a private company with no public stock price. No recent secondary market data is available.
How much is VectorBuilder worth (valuation)?
VectorBuilder's valuation is estimated at $1.0B based on funding round data.
Can I buy VectorBuilder stock?
VectorBuilder shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was VectorBuilder's last funding round?
VectorBuilder's most recent funding round was Series C Extension on July 26, 2023.
Who are the main investors in VectorBuilder?
Investor information for VectorBuilder is not publicly disclosed.
Will VectorBuilder IPO soon?
No public IPO plans have been announced for VectorBuilder.
How can I track VectorBuilder secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VectorBuilder's secondary market activity and sign up for updates.